INmune Bio
(NASDAQ) INMB
INmune Bio Financials at a Glance
Market Cap
$39.08M
Revenue (TTM)
$50.00K
Net Income (TTM)
$45.93M
EPS (TTM)
$-1.92
P/E Ratio
-0.76
Dividend
$0.00
Beta (Volatility)
1.50 (Average)
Dividend
$0.00
Beta (Volatility)
1.50 (Average)
Price
$1.42
Volume
3,578
Open
$1.46
Price
$1.42
Volume
3,578
Open
$1.46
Previous Close
$1.42
Daily Range
$1.41 - $1.46
52-Week Range
$1.09 - $11.64
Dividend
$0.00
Beta (Volatility)
1.50 (Average)
Price
$1.42
Volume
3,578
Open
$1.46
Previous Close
$1.42
Daily Range
$1.41 - $1.46
52-Week Range
$1.09 - $11.64
INMB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout INmune Bio
Industry
Biotechnology
Sector
Health CareEmployees
21
CEO
David J. Moss, MBA
Website
www.inmunebio.comHeadquarters
Boca Raton, FL 33432, US
INMB Financials
Key Financial Metrics (TTM)
Gross Margin
-68%
Operating Margin
-948%
Net Income Margin
-919%
Return on Equity
-165%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-1.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$39.08M
Shares Outstanding
26.59M
Volume
3.58K
Avg. Volume
415.14K
Financials (TTM)
Gross Profit
$50.00K
Operating Income
$30.87M
EBITDA
$30.79M
Operating Cash Flow
$22.58M
Capital Expenditure
$1.04M
Free Cash Flow
$23.62M
Cash & ST Invst.
$24.75M
Total Debt
$1.03M
INmune Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$56.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$39.08M
N/A
Market Cap/Employee
$3.01M
N/A
Employees
13
N/A
Net Income
$5.26M
+42.9%
EBITDA
$5.42M
+41.2%
Quarterly Fundamentals
Net Cash
$23.72M
+15.5%
Accounts Receivable
$4.54M
+222.3%
Inventory
$0.00
N/A
Long Term Debt
$411.00K
+68.4%
Short Term Debt
$623.00K
+345.0%
Return on Assets
-1.42%
N/A
Return on Invested Capital
-1.98%
N/A
Free Cash Flow
$3.66M
+66.8%
Operating Cash Flow
$2.96M
+73.2%